Greetings again from the darkness. The best thrillers often interweave multiple story lines to create a complex web of detail for viewers to unwind. Writer-director Nicholas Jarecki (ARBITRAGE, 2012) serves up three story lines, all related to the current Opioid crisis. Although the film looks great and has a deep cast, we’ve seen most of this before and no new insight is provided in regards to the struggle. Instead, it’s really standard thriller fare that never goes deep enough into any of the characters to make us care.
Armie Hammer (along with the recent personal baggage attached to him) stars as Jake Kelly, a DEA Agent who has worked undercover in hopes of exposing the Armenian-Canadian-American drug traffickers responsible for a significant portion of opioids crossing the border. Hammer spends the entire movie with an intensely furrowed brow that would likely inspire distrust amongst any potential drug syndicates.
In storyline number 2, Evangeline Lilly (Wasp in the ANT-MAN movies) is Claire Reimann, an architect and recovering drug addict, who is out for vengeance when her beloved high school athlete son is found dead with drugs in his system. The third segment features Oscar winner Gary Oldman (DARKEST HOUR, 2017) as Dr. Tyrone Brower, a science professor at a private Detroit university. He runs a drug-testing lab and faces a moral dilemma when questionable lab results for “the first non-addictive painkiller” puts people at risk, not to mention funding for his work.
Any one of these actors or stories could carry the weight of a movie, but when combined, they succeed only in crushing the entertainment value and tension level. Oldman’s story is easily the most interesting. It addresses how Big Pharma gets new drugs rubber-stamped by funding otherwise cash-strapped labs and schools. There is also the skepticism involved with the drug-producer’s influence over the supposedly independent FDA, and on top of all that, there is the ethical concerns of everyone putting the almighty dollar ahead of safety.
Director Jarecki (the brother of Andrew Jarecki who directed the superb 2003 documentary CAPTURING THE FRIEDMANS) kicks off the movie with a beautifully filmed, albeit brief, chase scene through the snowy Canadian forest. In fact, the camera work throughout is fine. It’s really the overloaded script that prevents any of the stories or characters from clicking. Mr. Oldman seems to sense that he needs to overcome the lack of complexity in his story, and because of the effort, loses his usual reserved cerebral approach for which he’s known.
Supporting work is provided by Greg Kinnear as the Dean willing to sacrifice ethics and friendship for money, Michelle Rodriguez as the DEA supervisor in a budget crunch, and Lily-Rose Depp as Jake’s strung out sister. Also contributing are Indira Varma, John Ralston, Martin Donovan, Mia Kirshner, Kid Cudi, Michael Aronov, Luke Evans, and Veronica Ferres. The weakest link here is director Jarecki himself, who for some reason, thought he could play Jake’s partner … a role that would have benefited from a more refined actor.
The horrific effects of the Opioid crisis are known to most, and the film plays like a Wikipedia explanation for anyone who doesn’t read or watch the news. Certainly not helping is the “Miami Vice” type score that accompanies many scenes, and the choppy editing that causes many scenes to fail. Better movies in this genre would include THE INSIDER (1999, ironically directed by “Miami Vice” creator Michael Mann) and Soderbergh’s TRAFFIC (2000). The obstacles faced by whistleblowers, the importance of funding to academia, budgetary concerns for law enforcement, the tragic impact of drugs on families, and the systemic corruption that has fueled the epidemic … all of these are touched on. It’s just that it all seems too obvious. If somehow you didn’t already know, the money-hungry don’t play fair – whether they be drug dealers or drug companies.
The film will hit theaters on February 26, 2021 and Digital and On Demand March 5, 2021